The scientists went on to investigate the effects of a cancer drug called deoxycoformycin
which makes it harder for tissues to remove adenosine.
He did not respond to treatment with interferon alfa ([Alpha]-IFN), but achieved long-term remission following treatment with deoxycoformycin
In the trials, Nipent, also known as pentostatin or deoxycoformycin
, produced a complete response in 68 percent of patients and a partial response in 7 percent of patients -- a combined (total) response of 75 percent.